Your current page already cites the most important trials SURMOUNT-1, SURPASS-2 and related diabetes work which is exactly the right evidence base for this section
Shaw K, Williams SP, Patrick M, ValenciaPrado M, Durkin MS, Howerton EM, Ladd-Acosta CM, Pas ET, Bakian AV, Bartholomew P, Nieves-Muoz N, Sidwell K, Alford A, Bilder DA, DiRienzo M, Fitzgerald RT, Furnier SM, Hudson A, Pokoski OM, Shea L, Tinker SC, Warren Z, Zahorodny W, Agosto-Rosa H, Anbar J, Chvez K, Esler A, Forkner A, Grzybowski A, Agib AH, Hallas L, Lopez M, Magaa S, Nguyen RHN, Parker J, Pierce K, Protho T, Torres H, Vanegas SB, Vehorn A, Zhang M, Andrews J, Greer FL, HallLande J, McArthur D, Mitamura M, Montes A, Pettygrove S, Shenouda J, Skowyra C, Washington A, Maenner MJ (2025) Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 yearsautism and developmental disabilities monitoring network, 16 sites, United States, 2022
[1] [2] Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with similar clinical effects
Eating a nutritious diet may lower your risk of experiencing semaglutide side effects
Choosing Your Injection Day Many people choose a Friday Night or Saturday Morning schedule